The GrantAdler Corporation is a medical device company specializing in innovative products for vascular access. Vascular access is required for treatment of many chronic and acute medical conditions and for the administration of contrast media used in diagnostic imaging. GrantAdler’s mission is to reduce healthcare costs and infection rates endured by patients undergoing chemotherapy and hemodialysis.

Rhapsody^® CT+ Power Port, the new standard for subcutaneous vascular access is taking the market by storm. Rhapsody’s SurePlace^TM High-Integrity Catheter System optimizes implantation speed, accuracy, and precision by simplifying the procedure, decreasing implant time, and increasing reproducibility. The patented coil reinforced catheter significantly reduces, if not eliminates, the potential for kinking, cracking, and fracturing, and drives down costs related to device complications.

The QuickConnect^TM design eliminates the need for extra parts to secure the catheter to the port. It also removes the frustration to the physician and the costs to the system that occur when new trays are opened to replace components lost to the non-sterile field.

QuickConnect provides implanting physicians with the added flexibility to either “pre-connect” the catheter to the port prior to implantation, or to “post-connect” them after implantation.

In addition to the Rhapsody CT+ SurePlace and QuickConnect design enhancements, the Rhapsody CT+ Power Port gives technicians and physicians the freedom to use any available power-rated needle to perform contrast-enhanced CT scans.

The Rhapsody CT+ Power Port provides healthcare professionals with the peace of mind that comes from knowing that the vascular access device they have chosen is the best solution for their patients. To begin your trial today, please contact your GrantAdler sales professional.